Furosemide stress test and interstitial fibrosis in kidney biopsies in chronic kidney disease
Abstract Background Interstitial fibrosis (IF) on kidney biopsy is one of the most potent risk factors for kidney disease progression. The furosemide stress test (FST) is a validated tool that predicts the severity of acute kidney injury (especially at 2 h) in critically ill patients. Since furosemi...
Main Authors: | Jesús Rivero, Francisco Rodríguez, Virgilia Soto, Etienne Macedo, Lakhmir S. Chawla, Ravindra L. Mehta, Sucheta Vaingankar, Pranav S. Garimella, Carlos Garza, Magdalena Madero |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-03-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12882-020-01721-z |
Similar Items
-
The furosemide stress test: current use and future potential
by: Blaithin A. McMahon, et al.
Published: (2021-01-01) -
Furosemide in Hypovolemic shock
by: Khalid Ali Khaleel
Published: (2020-12-01) -
Furosemide is associated with acute kidney injury in critically ill patients
by: T.M. Levi, et al.
Published: (2012-09-01) -
Furosemide is associated with acute kidney injury in critically ill patients
by: T.M. Levi, et al.
Published: (2012-09-01) -
Hospitalized patients received furosemide undergoing acute kidney injury: the risk and prediction tool
by: Chen Guan, et al.
Published: (2023-09-01)